SPDR Advertisement SureTrader SureTrader SPDR Advertisement
Home > Boards > US Listed > Medical - Drugs > Provectus Biopharmaceuticals Inc. (PVCT)

Fidelity says PVCT is invalid symbol now. Anyone

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
smt232 Member Profile
 
Followed By 0
Posts 41
Boards Moderated 0
Alias Born 01/15/14
160x600 placeholder
Advertisement
Provectus Biopharmaceuticals’ Phase 1 PV-10 Data on Liver Cancer Presented at 6th Asia-Pacific Primary Liver Cancer Expert ... "Business Wire" - 7/6/2015 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/6/2015 7:41:59 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 7/2/2015 6:32:53 AM
Provectus Biopharmaceuticals Signs Letter of Intent with Boehringer Ingelheim (China) to Collaborate in Bringing PV-10 to Mar... "Business Wire" - 7/2/2015 6:30:00 AM
Provectus Biopharmaceuticals’ Data on PV-10 for Chemoablation of Liver Cancers Presented at ESMO 17th World Congress on Gas... "Business Wire" - 7/2/2015 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/26/2015 9:01:52 AM
AAPI Honors Provectus Biopharmaceuticals During 33rd Annual Convention and Scientific Assembly "Business Wire" - 6/26/2015 9:00:00 AM
Provectus Biopharmaceuticals’ Data on PV-10 as Treatment for Melanoma Presented at 5th European Post-Chicago Melanoma / Ski... "Business Wire" - 6/26/2015 8:30:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/25/2015 8:02:47 AM
Provectus Biopharmaceuticals’ Poster Presentation Displayed on Phase 3 Study of PV-10 at 5th European Post-Chicago Melanoma... "Business Wire" - 6/25/2015 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/24/2015 4:03:19 PM
Provectus Biopharmaceuticals Announces Abstract Available on PV-10 for Chemoablation of Liver Cancers at ESMO 17th World Cong... "Business Wire" - 6/24/2015 4:02:00 PM
Provectus Biopharmaceuticals, Inc. Announces Closing of Public Offering "Business Wire" - 6/24/2015 4:01:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/22/2015 6:11:03 AM
Provectus Biopharmaceuticals Retains PharmaHEALTHLabs to Facilitate Investigator Advisory Board Meeting During 11Th Brazilian... "Business Wire" - 6/22/2015 6:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 6/19/2015 4:18:07 PM
Securities Registration (section 12(b)) (8-a12b) "Edgar (US Regulatory)" - 6/19/2015 9:09:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/19/2015 9:05:59 AM
Provectus Biopharmaceuticals, Inc. Announces Pricing of Public Offering to Raise $13.1 Million "Business Wire" - 6/19/2015 9:00:00 AM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 6/19/2015 6:07:04 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 6/19/2015 6:02:53 AM
Provectus Biopharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock and Warrants "Business Wire" - 6/18/2015 5:27:00 PM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/16/2015 6:07:37 AM
Abstract on Provectus Biopharmaceuticals’ PV-10 in Colon Cancer Models Published by Society of Surgical Oncology "Business Wire" - 6/16/2015 6:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 6/11/2015 6:06:26 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist